We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+38.09%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$106M
AUM Growth
+$11.3M
Cap. Flow
+$15.2M
Cap. Flow %
14.36%
Top 10 Hldgs %
96.58%
Holding
19
New
4
Increased
9
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
SBBP
Strongbridge Biopharma plc.
SBBP
+$4.98M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$4.72M
3
GLD icon
SPDR Gold Trust
GLD
+$1.7M
4
CRDF icon
Cardiff Oncology
CRDF
+$1.65M
5
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$1.51M

Top Sells

Rank Stock Value
1
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$1.96M
2
LITS
Lite Strategy Inc
LITS
+$362K
3
KURA icon
Kura Oncology
KURA
+$333K
4
ADXN
Addex Therapeutics
ADXN
+$242

Sector Composition

Rank Sector Weight
1 Healthcare 89.49%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
1
Cardiff Oncology
CRDF
$64.3M
$26.2M 24.69%
1,845,164
+250,000
+16% +$1.65M
MTEM
2
DELISTED
Molecular Templates, Inc.
MTEM
$23.2M 21.86%
141,533
+1,000
+0.7% +$178K
SBBP
3
DELISTED
Strongbridge Biopharma plc.
SBBP
$17M 16.02%
8,089,442
+1,477,377
+22% +$4.98M
CTIC
4
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$9.27M 8.74%
4,313,617
+3,694,157
+596% +$4.72M
SRRA
5
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$6.87M 6.48%
643,959
– –
KALA icon
6
KALA BIO
KALA
$11.8M
$5.79M 5.46%
309
+61
+25% +$1.4M
GLD icon
7
SPDR Gold Trust
GLD
$131B
$4.49M 4.23%
25,358
+9,435
+59% +$1.7M
GARS
8
DELISTED
Garrison Capital Inc.
GARS
$4.45M 4.19%
1,164,061
– –
SCYX icon
9
SCYNEXIS
SCYX
$37M
$3.68M 3.47%
104,296
+4,970
+5% +$243K
PSTH
10
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$1.53M 1.44%
+67,369
New +$1.51M
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.09M 1.02%
192,738
+67,967
+54% +$324K
EIGR
12
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$919K 0.87%
3,762
+1,029
+38% +$320K
CCIV.U
13
DELISTED
Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth
CCIV.U
$626K 0.59%
+62,500
New +$626K
LITS
14
Lite Strategy Inc
LITS
$33.6M
$548K 0.52%
8,778
-6,000
-41% -$362K
ADXN
15
Addex Therapeutics
ADXN
$213K 0.2%
870
-1
-0.1% -$242
EPIX
16
DELISTED
ESSA Pharma
EPIX
$183K 0.17%
+26,590
New +$180K
PSTH.WS
17
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$54K 0.05%
+7,485
New +$54.1K
KURA icon
18
Kura Oncology
KURA
$922M
– –
-20,406
Closed -$333K
STSA
19
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-68,172
Closed -$1.96M

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q3 2020 Portfolio in Review

As of Q3 2020, Caxton Corporation held 19 positions worth $106M, up 12% from $94.7M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Caxton Corporation deployed $15.2M of net new capital in Q3 2020, opening 4 new positions and adding to 9 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 67,369 shares worth $1.53M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 93% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Lite Strategy Inc, an estimated $362K trimmed.

  • Caxton Corporation's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 67,369 shares worth $1.53M.
  • Caxton Corporation added most to Strongbridge Biopharma plc. in Q3 2020, an estimated $4.98M increase.
  • Caxton Corporation's biggest Q3 2020 reduction was Lite Strategy Inc, cutting an estimated $362K.
  • Caxton Corporation fully exited Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020, selling an estimated $1.96M.
  • Caxton Corporation's ten largest holdings make up 97% of its $106M portfolio in Q3 2020.
  • Caxton Corporation opened 4 new positions and closed 2 in Q3 2020.
  • Caxton Corporation's portfolio value rose 12% quarter-over-quarter to $106M.

Based on Caxton Corporation's 13F filing for Q3 2020, filed 16 Nov 2020.